FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium valproate 300 mg gastro-resistant oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Sodium valproate 600 mg gastro-resistant oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Sodium valproate 600 mg gastro-resistant oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ascorbic acid 1 g and zinc citrate 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Ascorbic acid 1 g and zinc citrate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ascorbic acid 1 g and zinc citrate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa anhydrous (as carbidopa) 43.75 mg and entacapone 200 mg and levodopa 175 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely ibuprofen 150 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ibuprofen 150 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ibuprofen 150 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely diphenhydramine hydrochloride 12.5 milligram and paracetamol 500 milligram and pseudoephedrine hydrochloride 22.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diphenhydramine hydrochloride 12.5 milligram and paracetamol 500 milligram and pseudoephedrine hydrochloride 22.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely diphenhydramine hydrochloride 12.5 milligram and paracetamol 500 milligram and pseudoephedrine hydrochloride 22.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely diphenhydramine hydrochloride 12.5 milligram and paracetamol 500 milligram and pseudoephedrine hydrochloride 22.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dexketoprofen 25 milligram and tramadol hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dexketoprofen 25 milligram and tramadol hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dexketoprofen 25 milligram and tramadol hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Zonisamide 100 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Zonisamide 100 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely zonisamide 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely zonisamide 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely zonisamide 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely zonisamide 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paroxetine (as paroxetine hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 25 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 25 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 25 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely paroxetine (as paroxetine hydrochloride) 40 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paroxetine (as paroxetine hydrochloride) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely indapamide 625 microgram and perindopril tosilate 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely indapamide 625 microgram and perindopril tosilate 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely indapamide 625 microgram and perindopril tosilate 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely perindopril (as perindopril arginine) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely perindopril (as perindopril arginine) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ivacaftor 150 milligram and tezacaftor 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ivacaftor 150 milligram and tezacaftor 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ivacaftor 150 milligram and tezacaftor 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely ivacaftor 75 milligram and tezacaftor 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 86 of 87 End

This concept is not in any reference sets

Back to Start